BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Reddy M, Jugnee N, El Laboudi A, Spanudakis E, Anantharaja S, Oliver N. A randomized controlled pilot study of continuous glucose monitoring and flash glucose monitoring in people with Type 1 diabetes and impaired awareness of hypoglycaemia. Diabet Med 2018;35:483-90. [PMID: 29230878 DOI: 10.1111/dme.13561] [Cited by in Crossref: 107] [Cited by in F6Publishing: 83] [Article Influence: 21.4] [Reference Citation Analysis]
Number Citing Articles
1 Kramer G, Michalak L, Müller UA, Kloos C, Werner C, Kuniss N. Association between Flash Glucose Monitoring and Metabolic Control as well as Treatment Satisfaction in Outpatients With Diabetes Type 1. Exp Clin Endocrinol Diabetes 2021;129:303-8. [PMID: 31185506 DOI: 10.1055/a-0875-3988] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
2 Visser MM, Charleer S, Fieuws S, De Block C, Hilbrands R, Van Huffel L, Maes T, Vanhaverbeke G, Dirinck E, Myngheer N, Vercammen C, Nobels F, Keymeulen B, Mathieu C, Gillard P. Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial. Lancet 2021;397:2275-83. [PMID: 34089660 DOI: 10.1016/S0140-6736(21)00789-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
3 Avari P, Ramli R, Reddy M, Oliver N, Fothergill R. Rationale and protocol for the Assessment of Impact of Real-time Continuous Glucose Monitoring on people presenting with severe Hypoglycaemia (AIR-CGM) study. BMC Endocr Disord 2019;19:110. [PMID: 31655586 DOI: 10.1186/s12902-019-0439-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
4 Shah VN, Laffel LM, Wadwa RP, Garg SK. Performance of a Factory-Calibrated Real-Time Continuous Glucose Monitoring System Utilizing an Automated Sensor Applicator. Diabetes Technol Ther 2018;20:428-33. [PMID: 29923775 DOI: 10.1089/dia.2018.0143] [Cited by in Crossref: 67] [Cited by in F6Publishing: 60] [Article Influence: 16.8] [Reference Citation Analysis]
5 Préau Y, Galie S, Schaepelynck P, Armand M, Raccah D. Benefits of a Switch from Intermittently Scanned Continuous Glucose Monitoring (isCGM) to Real-Time (rt) CGM in Diabetes Type 1 Suboptimal Controlled Patients in Real-Life: A One-Year Prospective Study §. Sensors (Basel) 2021;21:6131. [PMID: 34577338 DOI: 10.3390/s21186131] [Reference Citation Analysis]
6 Abraham SB, Arunachalam S, Zhong A, Agrawal P, Cohen O, McMahon CM. Improved Real-World Glycemic Control With Continuous Glucose Monitoring System Predictive Alerts. J Diabetes Sci Technol 2021;15:91-7. [PMID: 31272204 DOI: 10.1177/1932296819859334] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
7 Kraaijeveld SR. Continuous Glucose Monitoring as a Matter of Justice. HEC Forum 2021;33:345-70. [PMID: 32440803 DOI: 10.1007/s10730-020-09413-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Burckhardt M, Abraham MB, Dart J, Smith GJ, Paramalingam N, O'dea J, de Bock M, Davis EA, Jones TW. Impact of Hybrid Closed Loop Therapy on Hypoglycemia Awareness in Individuals with Type 1 Diabetes and Impaired Hypoglycemia Awareness. Diabetes Technology & Therapeutics 2021;23:482-90. [DOI: 10.1089/dia.2020.0593] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Tanenbaum ML, Commissariat PV. Barriers and Facilitators to Diabetes Device Adoption for People with Type 1 Diabetes. Curr Diab Rep 2022. [PMID: 35522355 DOI: 10.1007/s11892-022-01469-w] [Reference Citation Analysis]
10 Amiel SA, Choudhary P, Jacob P, Smith EL, De Zoysa N, Gonder-Frederick L, Kendall M, Heller S, Brooks A, Toschi E, Kariyawasam D, Potts L, Healy A, Rogers H, Sevdalis N, Stadler M, Qayyum M, Bakolis I, Goldsmith K. Hypoglycaemia Awareness Restoration Programme for People with Type 1 Diabetes and Problematic Hypoglycaemia Persisting Despite Optimised Self-care (HARPdoc): protocol for a group randomised controlled trial of a novel intervention addressing cognitions. BMJ Open 2019;9:e030356. [PMID: 31209097 DOI: 10.1136/bmjopen-2019-030356] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
11 Murphy HR, Holt RIG. Technology: an increasingly important component in the management of diabetes. Diabet Med 2018;35:407-8. [DOI: 10.1111/dme.13599] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Clubbs Coldron B, Coates V, Khamis A, MacRury S. Use of Continuous Glucose Monitoring in Non-ICU Hospital Settings for People With Diabetes: A Scoping Review of Emerging Benefits and Issues. J Diabetes Sci Technol 2021;:19322968211053652. [PMID: 34696622 DOI: 10.1177/19322968211053652] [Reference Citation Analysis]
13 Porcellati F, Di Mauro S, Mazzieri A, Scamporrino A, Filippello A, De Fano M, Fanelli CG, Purrello F, Malaguarnera R, Piro S. Glucagon as a Therapeutic Approach to Severe Hypoglycemia: After 100 Years, Is It Still the Antidote of Insulin? Biomolecules 2021;11:1281. [PMID: 34572493 DOI: 10.3390/biom11091281] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Reddy M, Oliver N. Self-Monitoring of Blood Glucose Requirements with the Use of Intermittently Scanned Continuous Glucose Monitoring. Diabetes Technol Ther 2020;22:235-8. [PMID: 31833786 DOI: 10.1089/dia.2019.0369] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Whitehouse P, Kadis T, Jayagopal V. FreeStyle Libre and diabetes distress: a pilot analysis in a real‐life secondary care clinic setting. Pract Diab 2020;37:91-2. [DOI: 10.1002/pdi.2277] [Reference Citation Analysis]
16 Puhr S, Derdzinski M, Welsh JB, Parker AS, Walker T, Price DA. Real-World Hypoglycemia Avoidance with a Continuous Glucose Monitoring System's Predictive Low Glucose Alert. Diabetes Technol Ther 2019;21:155-8. [PMID: 30896290 DOI: 10.1089/dia.2018.0359] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 7.3] [Reference Citation Analysis]
17 Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, Bosi E, Buckingham BA, Cefalu WT, Close KL, Cobelli C, Dassau E, DeVries JH, Donaghue KC, Dovc K, Doyle FJ 3rd, Garg S, Grunberger G, Heller S, Heinemann L, Hirsch IB, Hovorka R, Jia W, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Levine B, Mayorov A, Mathieu C, Murphy HR, Nimri R, Nørgaard K, Parkin CG, Renard E, Rodbard D, Saboo B, Schatz D, Stoner K, Urakami T, Weinzimer SA, Phillip M. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Diabetes Care 2019;42:1593-603. [PMID: 31177185 DOI: 10.2337/dci19-0028] [Cited by in Crossref: 688] [Cited by in F6Publishing: 519] [Article Influence: 229.3] [Reference Citation Analysis]
18 Ajjan R, Slattery D, Wright E. Continuous Glucose Monitoring: A Brief Review for Primary Care Practitioners. Adv Ther 2019;36:579-96. [PMID: 30659511 DOI: 10.1007/s12325-019-0870-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
19 Oliver N, Reddy M. Reply to Seibold and Schlaeger: Comparison of continuous and flash glucose monitoring in Type 1 diabetes: methodological inconsistency precludes hypoglycaemia conclusions. Diabet Med 2018;35:1619-20. [PMID: 30058201 DOI: 10.1111/dme.13785] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
20 Hásková A, Radovnická L, Petruželková L, Parkin CG, Grunberger G, Horová E, Navrátilová V, Kádě O, Matoulek M, Prázný M, Šoupal J. Real-time CGM Is Superior to Flash Glucose Monitoring for Glucose Control in Type 1 Diabetes: The CORRIDA Randomized Controlled Trial. Diabetes Care 2020;43:2744-50. [PMID: 32859607 DOI: 10.2337/dc20-0112] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
21 Elbalshy M, Boucher S, Galland B, Haszard JJ, Crocket H, Wiltshire E, Jefferies C, de Bock MI, Tomlinson P, Jones S, Wheeler BJ. The MiaoMiao study: can do-it-yourself continuous glucose monitoring technology improve fear of hypoglycaemia in parents of children affected by type 1 diabetes? J Diabetes Metab Disord 2020;19:1647-58. [PMID: 33553041 DOI: 10.1007/s40200-020-00671-5] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Ibrahim M, Baker J, Cahn A, Eckel RH, El Sayed NA, Fischl AH, Gaede P, Leslie RD, Pieralice S, Tuccinardi D, Pozzilli P, Richelsen B, Roitman E, Standl E, Toledano Y, Tuomilehto J, Weber SL, Umpierrez GE. Hypoglycaemia and its management in primary care setting. Diabetes Metab Res Rev 2020;36:e3332. [PMID: 32343474 DOI: 10.1002/dmrr.3332] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
23 Riddell MC, Shakeri D, Scott SN. A Brief Review on the Evolution of Technology in Exercise and Sport in Type 1 Diabetes: Past, Present, and Future. Diabetes Technol Ther 2021. [PMID: 34809493 DOI: 10.1089/dia.2021.0427] [Reference Citation Analysis]
24 Castellano-Guerrero AM, Guerrero R, Ruiz-Aranda D, Perea S, Pumar A, Relimpio F, Mangas MA, Losada F, Martínez-Brocca MA. Gender differences in quality of life in adults with long-standing type 1 diabetes mellitus. Diabetol Metab Syndr 2020;12:64. [PMID: 32695233 DOI: 10.1186/s13098-020-00571-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
25 Kruger DF, Edelman SV, Hinnen DA, Parkin CG. Reference Guide for Integrating Continuous Glucose Monitoring Into Clinical Practice. Diabetes Educ 2019;45:3S-20S. [PMID: 30541402 DOI: 10.1177/0145721718818066] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
26 Pedone E, Laurenzi A, Allora A, Bolla AM, Caretto A. Insulin pump therapy and continuous glucose monitoring in adults with type 2 diabetes: where are we now? Exploration of Medicine 2020;1:314-30. [DOI: 10.37349/emed.2020.00021] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Seibold A, Schlaeger C. Comparison of continuous and flash glucose monitoring in Type 1 diabetes: methodological inconsistency precludes hypoglycaemia conclusions. Diabet Med 2018;35:1618-9. [DOI: 10.1111/dme.13696] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
28 Bosi E, Choudhary P, de Valk HW, Lablanche S, Castañeda J, de Portu S, Da Silva J, Ré R, Vorrink-de Groot L, Shin J, Kaufman FR, Cohen O, Laurenzi A, Caretto A, Slatterly D, Henderson-wilson M, Weisnagel SJ, Dubé M, Julien V, Trevisan R, Lepore G, Bellante R, Hramiak I, Spaic T, Driscoll M, Borot S, Clergeot A, Khiat L, Hammond P, Ray S, Dinning L, Tonolo G, Manconi A, Ledda MS, de Ranitz W, Silvius B, Wojtusciszyn A, Farret A, Vriesendorp T, Immeker-de Jong F, van der Linden J, Brink HS, Alkemade M, Schaepelynck-belicar P, Galie S, Tréglia C, Benhamou P, Haddouche M, Hoogma R, Leelarathna L, Shaju A, James L. Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial. The Lancet Diabetes & Endocrinology 2019;7:462-72. [DOI: 10.1016/s2213-8587(19)30150-0] [Cited by in Crossref: 37] [Cited by in F6Publishing: 8] [Article Influence: 12.3] [Reference Citation Analysis]
29 Zaharieva DP, Messer LH, Paldus B, O’neal DN, Maahs DM, Riddell MC. Glucose Control During Physical Activity and Exercise Using Closed Loop Technology in Adults and Adolescents with Type 1 Diabetes. Canadian Journal of Diabetes 2020;44:740-9. [DOI: 10.1016/j.jcjd.2020.06.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
30 Welsh JB. Role of Continuous Glucose Monitoring in Insulin-Requiring Patients with Diabetes. Diabetes Technology & Therapeutics 2018;20:S2-42-9. [DOI: 10.1089/dia.2018.0100] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
31 De Ridder F, den Brinker M, De Block C. The road from intermittently scanned continuous glucose monitoring to hybrid closed-loop systems. Part B: results from randomized controlled trials. Ther Adv Endocrinol Metab 2019;10:2042018819871903. [PMID: 31516690 DOI: 10.1177/2042018819871903] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
32 De Ridder F, den Brinker M, De Block C. The road from intermittently scanned glucose monitoring to hybrid closed-loop systems: Part A. Keys to success: subject profiles, choice of systems, education. Ther Adv Endocrinol Metab 2019;10:2042018819865399. [PMID: 31384420 DOI: 10.1177/2042018819865399] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
33 Draznin B, Aroda VR, Bakris G, Benson G, Brown FM, Freeman R, Green J, Huang E, Isaacs D, Kahan S, Leon J, Lyons SK, Peters AL, Prahalad P, Reusch JEB, Young-Hyman D, Das S, Kosiborod M; American Diabetes Association Professional Practice Committee., American Diabetes Association Professional Practice Committee:. 7. Diabetes Technology: Standards of Medical Care in Diabetes-2022. Diabetes Care 2022;45:S97-S112. [PMID: 34964871 DOI: 10.2337/dc22-S007] [Reference Citation Analysis]
34 Macaulay GC, Boucher SE, Yogarajah A, Galland BC, Wheeler BJ. Sleep and Night-time Caregiving in Parents of Children and Adolescents with Type 1 Diabetes Mellitus - A Qualitative Study. Behav Sleep Med 2020;18:622-36. [PMID: 31370700 DOI: 10.1080/15402002.2019.1647207] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
35 Lin YK, Fisher SJ, Pop-Busui R. Hypoglycemia unawareness and autonomic dysfunction in diabetes: Lessons learned and roles of diabetes technologies. J Diabetes Investig 2020;11:1388-402. [PMID: 32403204 DOI: 10.1111/jdi.13290] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
36 Choudhary P, Campbell F, Joule N, Kar P; Diabetes UK. A Type 1 diabetes technology pathway: consensus statement for the use of technology in Type 1 diabetes. Diabet Med 2019;36:531-8. [PMID: 30773681 DOI: 10.1111/dme.13933] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
37 Dagdelen S, Deyneli O, Dinccag N, Ilkova H, Osar Siva Z, Yetkin I, Yilmaz T. Expert Panel Recommendations for Use of Standardized Glucose Reporting System Based on Standardized Glucometrics Plus Visual Ambulatory Glucose Profile (AGP) Data in Clinical Practice. Front Endocrinol 2022;12:663222. [DOI: 10.3389/fendo.2021.663222] [Reference Citation Analysis]
38 Elbalshy M, Boucher S, Crocket H, Galland B, MacKenzie C, de Bock MI, Jefferies C, Wiltshire E, Wheeler BJ. Exploring Parental Experiences of Using a Do-It-Yourself Solution for Continuous Glucose Monitoring Among Children and Adolescents With Type 1 Diabetes: A Qualitative Study. J Diabetes Sci Technol 2020;14:844-53. [PMID: 31875411 DOI: 10.1177/1932296819895290] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
39 Adolfsson P, Parkin CG, Thomas A, Krinelke LG. Selecting the Appropriate Continuous Glucose Monitoring System - a Practical Approach. Eur Endocrinol 2018;14:24-9. [PMID: 29922348 DOI: 10.17925/EE.2018.14.1.24] [Cited by in Crossref: 25] [Cited by in F6Publishing: 10] [Article Influence: 6.3] [Reference Citation Analysis]
40 Landau Z, Abiri S, Gruber N, Levy-shraga Y, Brener A, Lebenthal Y, Barash G, Pinhas-hamiel O, Rachmiel M. Use of flash glucose-sensing technology (FreeStyle Libre) in youth with type 1 diabetes: AWeSoMe study group real-life observational experience. Acta Diabetol 2018;55:1303-10. [DOI: 10.1007/s00592-018-1218-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
41 Wyckoff JA, Brown FM. Time in Range in Pregnancy: Is There a Role? Diabetes Spectr 2021;34:119-32. [PMID: 34149252 DOI: 10.2337/ds20-0103] [Reference Citation Analysis]
42 Polsky S. Is It Safe to Use "On-Demand" Continuous Glucose Monitoring During Pregnancy? Diabetes Technol Ther 2018;20:177-9. [PMID: 29565718 DOI: 10.1089/dia.2018.0035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
43 Reddy M, Jugnee N, Anantharaja S, Oliver N. Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study. Diabetes Technol Ther 2018;20:751-7. [PMID: 30265562 DOI: 10.1089/dia.2018.0252] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 8.5] [Reference Citation Analysis]
44 Messaaoui A, Tenoutasse S, Crenier L. Flash Glucose Monitoring Accepted in Daily Life of Children and Adolescents with Type 1 Diabetes and Reduction of Severe Hypoglycemia in Real-Life Use. Diabetes Technol Ther 2019;21:329-35. [PMID: 31058545 DOI: 10.1089/dia.2018.0339] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
45 Tagougui S, Taleb N, Rabasa-Lhoret R. The Benefits and Limits of Technological Advances in Glucose Management Around Physical Activity in Patients Type 1 Diabetes. Front Endocrinol (Lausanne) 2018;9:818. [PMID: 30713524 DOI: 10.3389/fendo.2018.00818] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
46 Dicembrini I, Cosentino C, Monami M, Mannucci E, Pala L. Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials. Acta Diabetol 2021;58:401-10. [PMID: 32789691 DOI: 10.1007/s00592-020-01589-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 De Valk HW, Lablanche S, Bosi E, Choudhary P, Silva JD, Castaneda J, Vorrink L, De Portu S, Cohen O. Study of MiniMed 640G Insulin Pump with SmartGuard in Prevention of Low Glucose Events in Adults with Type 1 Diabetes (SMILE): Design of a Hypoglycemia Prevention Trial with Continuous Glucose Monitoring Data as Outcomes. Diabetes Technol Ther 2018;20:758-66. [PMID: 30325656 DOI: 10.1089/dia.2018.0222] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
48 Nana M, Moore S, Ang E, Lee Z, Bondugulapati L. Flash glucose monitoring: Impact on markers of glycaemic control and patient-reported outcomes in individuals with type 1 diabetes mellitus in the real-world setting. Diabetes Research and Clinical Practice 2019;157:107893. [DOI: 10.1016/j.diabres.2019.107893] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
49 Reddy M, Oliver N. Reply to Letter by Seibold regarding Monika Reddy, Narvada Jugnee, Sinthuka Anantharaja, and Nick Oliver, Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study. Diabetes Technol Ther 2019;21:99-100. [PMID: 30707618 DOI: 10.1089/dia.2018.0378] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Bianchi C, Aragona M, Rodia C, Baronti W, de Gennaro G, Bertolotto A, Del Prato S. Freestyle Libre trend arrows for the management of adults with insulin-treated diabetes: A practical approach. J Diabetes Complications 2019;33:6-12. [PMID: 30446477 DOI: 10.1016/j.jdiacomp.2018.10.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
51 Moser O, Ziko H, Elsayed H, Hochfellner DA, Pöttler T, Mueller A, Eckstein ML, Sourij H, Mader JK; Hypo-RESOLVE Consortium. People with type 1 diabetes and impaired awareness of hypoglycaemia have a delayed reaction to performing a glucose scan during hypoglycaemia: a prospective observational study. Diabet Med 2020;37:2153-9. [PMID: 32638428 DOI: 10.1111/dme.14362] [Reference Citation Analysis]
52 Gordon I, Rutherford C, Makarounas-kirchmann K, Kirchmann M. Meta-analysis of average change in laboratory-measured HbA1c among people with type 1 diabetes mellitus using the 14 day Flash Glucose Monitoring System. Diabetes Research and Clinical Practice 2020;164:108158. [DOI: 10.1016/j.diabres.2020.108158] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
53 Alcántara-Aragón V. Improving patient self-care using diabetes technologies. Ther Adv Endocrinol Metab 2019;10:2042018818824215. [PMID: 30728941 DOI: 10.1177/2042018818824215] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 6.3] [Reference Citation Analysis]
54 Longo R, Sperling S. Personal Versus Professional Continuous Glucose Monitoring: When to Use Which on Whom. Diabetes Spectr 2019;32:183-93. [PMID: 31462872 DOI: 10.2337/ds18-0093] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
55 Al Hayek AA, Robert AA, Al Dawish MA. Acceptability of the FreeStyle Libre Flash Glucose Monitoring System: The Experience of Young Patients With Type 1 Diabetes. Clin Med Insights Endocrinol Diabetes 2020;13:1179551420910122. [PMID: 32206014 DOI: 10.1177/1179551420910122] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
56 Choudhary P, Portu S, Arrieta A, Castañeda J, Campbell FM. Use of sensor‐integrated pump therapy to reduce hypoglycaemia in people with Type 1 diabetes: a real‐world study in the UK. Diabet Med 2019;36:1100-8. [DOI: 10.1111/dme.14043] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
57 Suzuki J, Urakami T, Yoshida K, Kuwabara R, Mine Y, Aoki M, Morioka I. Association between scanning frequency of flash glucose monitoring and continuous glucose monitoring‐derived glycemic makers in children and adolescents with type 1 diabetes. Pediatrics International 2021;63:154-9. [DOI: 10.1111/ped.14412] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
58 Sampedro F, Stantonyonge N, Martínez-Horta S, Alcolea D, Lleó A, Muñoz L, Pérez-González R, Marín-Lahoz J, Gómez-Ansón B, Chico A. Increased plasma neurofilament light chain levels in patients with type-1 diabetes with impaired awareness of hypoglycemia. BMJ Open Diabetes Res Care 2020;8:e001516. [PMID: 32636221 DOI: 10.1136/bmjdrc-2020-001516] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
59 Avari P, Moscardo V, Jugnee N, Oliver N, Reddy M. Glycemic Variability and Hypoglycemic Excursions With Continuous Glucose Monitoring Compared to Intermittently Scanned Continuous Glucose Monitoring in Adults With Highest Risk Type 1 Diabetes. J Diabetes Sci Technol 2020;14:567-74. [PMID: 31375042 DOI: 10.1177/1932296819867688] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
60 Peters AL, Ahmann AJ, Hirsch IB, Raymond JK. Advances in Glucose Monitoring and Automated Insulin Delivery: Supplement to Endocrine Society Clinical Practice Guidelines. J Endocr Soc 2018;2:1214-25. [PMID: 30324178 DOI: 10.1210/js.2018-00262] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
61 Tauschmann M, Hovorka R. Technology in the management of type 1 diabetes mellitus - current status and future prospects. Nat Rev Endocrinol 2018;14:464-75. [PMID: 29946127 DOI: 10.1038/s41574-018-0044-y] [Cited by in Crossref: 51] [Cited by in F6Publishing: 42] [Article Influence: 17.0] [Reference Citation Analysis]
62 Al Hayek AA, Robert AA, Al Dawish MA. Differences of FreeStyle Libre Flash Glucose Monitoring System and Finger Pricks on Clinical Characteristics and Glucose Monitoring Satisfactions in Type 1 Diabetes Using Insulin Pump. Clin Med Insights Endocrinol Diabetes 2019;12:1179551419861102. [PMID: 31308786 DOI: 10.1177/1179551419861102] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
63 Seibold A. Regarding: Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study-Concerns that Reduce Confidence in Conclusions regarding Hypoglycemia. Diabetes Technol Ther 2019;21:97-8. [PMID: 30707620 DOI: 10.1089/dia.2018.0358] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
64 Gehr B, Biester T. Kontinuierliche Glukosemessung: Auf dem Weg zum Standard in der Diabetestherapie. Diabetologe 2018;14:417-32. [DOI: 10.1007/s11428-018-0383-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
65 Nathanson D, Svensson AM, Miftaraj M, Franzén S, Bolinder J, Eeg-Olofsson K. Effect of flash glucose monitoring in adults with type 1 diabetes: a nationwide, longitudinal observational study of 14,372 flash users compared with 7691 glucose sensor naive controls. Diabetologia 2021;64:1595-603. [PMID: 33774713 DOI: 10.1007/s00125-021-05437-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Rayannavar A, Elci OU, Mitteer L, De León DD. Continuous Glucose Monitoring Systems: Are They Useful for Evaluating Glycemic Control in Children with Hyperinsulinism? Horm Res Paediatr 2019;92:319-27. [PMID: 32208390 DOI: 10.1159/000506230] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
67 Lin YK, Groat D, Chan O, Hung M, Sharma A, Varner MW, Gouripeddi R, Facelli JC, Fisher SJ. Associations Between the Time in Hypoglycemia and Hypoglycemia Awareness Status in Type 1 Diabetes Patients Using Continuous Glucose Monitoring Systems. Diabetes Technol Ther 2020;22:787-93. [PMID: 32267773 DOI: 10.1089/dia.2020.0016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Dovc K, Battelino T. Time in range centered diabetes care. Clin Pediatr Endocrinol 2021;30:1-10. [PMID: 33446946 DOI: 10.1297/cpe.30.1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
69 Argento NB. Flash Glucose Monitoring: A Patient's and Clinician's Caveats and Concerns. Endocrine Practice 2018;24:928-31. [DOI: 10.4158/ep-2018-0216] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
70 Ang E, Lee ZX, Moore S, Nana M. Flash glucose monitoring (FGM): A clinical review on glycaemic outcomes and impact on quality of life. Journal of Diabetes and its Complications 2020;34:107559. [DOI: 10.1016/j.jdiacomp.2020.107559] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
71 Adolfsson P, Rentoul D, Klinkenbijl B, Parkin CG. Hypoglycaemia Remains the Key Obstacle to Optimal Glycaemic Control - Continuous Glucose Monitoring is the Solution. Eur Endocrinol. 2018;14:50-56. [PMID: 30349594 DOI: 10.17925/ee.2018.14.2.50] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
72 Choudhary P, Amiel SA. Hypoglycaemia in type 1 diabetes: technological treatments, their limitations and the place of psychology. Diabetologia 2018;61:761-9. [PMID: 29423581 DOI: 10.1007/s00125-018-4566-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.8] [Reference Citation Analysis]
73 Song J, Zhang C, Kong S, Liu F, Hu W, Su F, Li S. Novel chitosan based metal-organic polyhedrons/enzyme hybrid hydrogel with antibacterial activity to promote wound healing. Carbohydrate Polymers 2022;291:119522. [DOI: 10.1016/j.carbpol.2022.119522] [Reference Citation Analysis]
74 Marsters BL, Boucher SE, Galland BC, Wiltshire EJ, de Bock MI, Tomlinson PA, Rayns J, MacKenzie KE, Chan H, Wheeler BJ. Cutaneous adverse events in a randomized controlled trial of flash glucose monitoring among youth with type 1 diabetes mellitus. Pediatr Diabetes 2020;21:1516-24. [PMID: 32935921 DOI: 10.1111/pedi.13121] [Reference Citation Analysis]
75 Reddy M, Jugnee N, El Laboudi A, Spanudakis E, Anantharaja S, Oliver N. A randomized controlled pilot study of continuous glucose monitoring and flash glucose monitoring in people with Type 1 diabetes and impaired awareness of hypoglycaemia. Diabet Med 2018;35:483-90. [PMID: 29230878 DOI: 10.1111/dme.13561] [Cited by in Crossref: 107] [Cited by in F6Publishing: 83] [Article Influence: 21.4] [Reference Citation Analysis]
76 Pemberton JS, Kershaw M, Dias R, Idkowiak J, Mohamed Z, Saraff V, Barrett TG, Krone R, Uday S. DYNAMIC: Dynamic glucose management strategies delivered through a structured education program improves time in range in a socioeconomically deprived cohort of children and young people with type 1 diabetes with a history of hypoglycemia. Pediatr Diabetes 2021;22:249-60. [PMID: 33205572 DOI: 10.1111/pedi.13155] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
77 Evans M, Welsh Z, Ells S, Seibold A. The Impact of Flash Glucose Monitoring on Glycaemic Control as Measured by HbA1c: A Meta-analysis of Clinical Trials and Real-World Observational Studies. Diabetes Ther 2020;11:83-95. [PMID: 31673972 DOI: 10.1007/s13300-019-00720-0] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 12.3] [Reference Citation Analysis]
78 Kublin O, Stępień M. Effect of Using Additional Readers for Flash Glucose Monitoring System on Metabolic Control, Safety, and the Incidence of Complications in Patients With Diabetes Mellitus. J Diabetes Sci Technol. 2020;1932296819900257. [PMID: 31948275 DOI: 10.1177/1932296819900257] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
79 Michalak A, Pagacz K, Młynarski W, Szadkowska A, Fendler W. Discrepancies between methods of continuous glucose monitoring in key metrics of glucose control in children with type 1 diabetes. Pediatr Diabetes 2019. [DOI: 10.1111/pedi.12854] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
80 Cowart K, Updike W, Bullers K. Systematic Review of Randomized Controlled Trials Evaluating Glycemic Efficacy and Patient Satisfaction of Intermittent-Scanned Continuous Glucose Monitoring in Patients with Diabetes. Diabetes Technol Ther 2020;22:337-45. [PMID: 31859531 DOI: 10.1089/dia.2019.0345] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
81 Sepúlveda E, Poínhos R, Nata G, Carvalho D, Neves JS, Seixas D, Choudhary P, Vicente SG, Amiel SA. Differentiating Hypoglycemia Awareness Status from Hypoglycemia Experience in Tools for Measuring Impaired Awareness of Hypoglycemia. Diabetes Technol Ther 2020;22:541-5. [PMID: 32175769 DOI: 10.1089/dia.2020.0034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
82 Aggarwal A, Pathak S, Goyal R. Clinical and Economic Outcomes of Continuous Glucose Monitoring System (CGMS) in Patients with Diabetes Mellitus: A Systematic Literature Review. Diabetes Research and Clinical Practice 2022. [DOI: 10.1016/j.diabres.2022.109825] [Reference Citation Analysis]
83 Zhou Y, Deng H, Liu H, Yang D, Xu W, Yao B, Yan J, Weng J. Effects of novel flash glucose monitoring system on glycaemic control in adult patients with type 1 diabetes mellitus: protocol of a multicentre randomised controlled trial. BMJ Open 2020;10:e039400. [PMID: 33277281 DOI: 10.1136/bmjopen-2020-039400] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
84 Oliver N, Avari P, Reddy M. Response to Letter by Seibold regarding "Glycemic Variability and Hypoglycemic Excursions With Continuous Glucose Monitoring Compared to Intermittently Scanned Continuous Glucose Monitoring in Adults With Highest Risk Type 1 Diabetes". J Diabetes Sci Technol 2020;14:697-8. [PMID: 32052652 DOI: 10.1177/1932296820904448] [Reference Citation Analysis]
85 Puhr S, Derdzinski M, Parker AS, Welsh JB, Price DA. Real-World Hypoglycemia Avoidance With a Predictive Low Glucose Alert Does Not Depend on Frequent Screen Views. J Diabetes Sci Technol 2020;14:83-6. [PMID: 30943780 DOI: 10.1177/1932296819840691] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
86 Draznin B, Aroda VR, Bakris G, Benson G, Brown FM, Freeman R, Green J, Huang E, Isaacs D, Kahan S, Leon J, Lyons SK, Peters AL, Prahalad P, Reusch JEB, Young-Hyman D, Das S, Kosiborod M; American Diabetes Association Professional Practice Committee., American Diabetes Association Professional Practice Committee:. 6. Glycemic Targets: Standards of Medical Care in Diabetes-2022. Diabetes Care 2022;45:S83-96. [PMID: 34964868 DOI: 10.2337/dc22-S006] [Reference Citation Analysis]
87 Wadwa RP, Laffel LM, Shah VN, Garg SK. Accuracy of a Factory-Calibrated, Real-Time Continuous Glucose Monitoring System During 10 Days of Use in Youth and Adults with Diabetes. Diabetes Technol Ther 2018;20:395-402. [PMID: 29901421 DOI: 10.1089/dia.2018.0150] [Cited by in Crossref: 65] [Cited by in F6Publishing: 47] [Article Influence: 16.3] [Reference Citation Analysis]
88 Kraaijeveld SR. Continuous Glucose Monitoring as a Matter of Justice. HEC Forum. [DOI: 10.1007/s10730-020-09413-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
89 Miller EM. Using Continuous Glucose Monitoring in Clinical Practice. Clin Diabetes 2020;38:429-38. [PMID: 33384468 DOI: 10.2337/cd20-0043] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
90 Cheng AYY, Feig DS, Ho J, Siemens R; Diabetes Canada Clinical Practice Guidelines Expert Working Group., Diabetes Canada Clinical Practice Guidelines Steering Committee. Blood Glucose Monitoring in Adults and Children with Diabetes: Update 2021. Can J Diabetes 2021;45:580-7. [PMID: 34511234 DOI: 10.1016/j.jcjd.2021.07.003] [Reference Citation Analysis]
91 Wilson C, Morant S, Kane S, Pesterfield C, Guest C, Rooney NJ. An Owner-Independent Investigation of Diabetes Alert Dog Performance. Front Vet Sci 2019;6:91. [PMID: 30972346 DOI: 10.3389/fvets.2019.00091] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
92 Davis TM, Dwyer P, England M, Fegan PG, Davis WA. Efficacy of Intermittently Scanned Continuous Glucose Monitoring in the Prevention of Recurrent Severe Hypoglycemia. Diabetes Technology & Therapeutics 2020;22:367-73. [DOI: 10.1089/dia.2019.0331] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
93 Urakami T, Yoshida K, Kuwabara R, Mine Y, Aoki M, Suzuki J, Morioka I. Frequent scanning using flash glucose monitoring contributes to better glycemic control in children and adolescents with type 1 diabetes. J Diabetes Investig 2021. [PMID: 34143544 DOI: 10.1111/jdi.13618] [Reference Citation Analysis]
94 Giani E, Macedoni M, Barilli A, Petitti A, Mameli C, Bosetti A, Cristiano A, Radovanovic D, Santus P, Zuccotti GV. Performance of the Flash Glucose Monitoring System during exercise in youth with Type 1 diabetes. Diabetes Research and Clinical Practice 2018;146:321-9. [DOI: 10.1016/j.diabres.2018.10.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
95 Reddy M, Oliver N. Self-Monitoring of Blood Glucose Requirements with the Use of Intermittently Scanned Continuous Glucose Monitoring: A Follow-Up Analysis Using Real-Life Data. Diabetes Technol Ther 2021;23:392-6. [PMID: 33253595 DOI: 10.1089/dia.2020.0477] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
96 Yan R, Li H, Kong X, Zhai X, Chen M, Sun Y, Ye L, Su X, Ma J. The Accuracy and Precision of the Continuously Stored Data from Flash Glucose Monitoring System in Type 2 Diabetes Patients during Standard Meal Tolerance Test. Int J Endocrinol 2020;2020:5947680. [PMID: 32377186 DOI: 10.1155/2020/5947680] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
97 Thomas MG, Avari P, Godsland IF, Lett AM, Reddy M, Oliver N. Optimizing type 1 diabetes after multiple daily injections and capillary blood monitoring: Pump or sensor first? A meta-analysis using pooled differences in outcome measures. Diabetes Obes Metab 2021. [PMID: 34286892 DOI: 10.1111/dom.14498] [Reference Citation Analysis]
98 Canecki Varzic S, Steiner K, Gradinjan Centner M, Grgurevic M, Cigrovski Berkovic M, Klobucar Majanovic S, Radman M, Milicevic T, Rahelic D, Bilic Curcic I. Assessment of FreeStyle Libre Flash Glucose Monitoring System Implementation in Real Life Clinical Setting: A Prospective Observational Study. Diagnostics (Basel) 2021;11:305. [PMID: 33668675 DOI: 10.3390/diagnostics11020305] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
99 Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, Bosi E, Buckingham BA, Cefalu WT, Close KL, Cobelli C, Dassau E, DeVries JH, Donaghue KC, Dovc K, Doyle FJ 3rd, Garg S, Grunberger G, Heller S, Heinemann L, Hirsch IB, Hovorka R, Jia W, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Levine B, Mayorov A, Mathieu C, Murphy HR, Nimri R, Nørgaard K, Parkin CG, Renard E, Rodbard D, Saboo B, Schatz D, Stoner K, Urakami T, Weinzimer SA, Phillip M. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Diabetes Care 2019;42:1593-603. [PMID: 31177185 DOI: 10.2337/dci19-0028] [Cited by in Crossref: 914] [Cited by in F6Publishing: 1] [Article Influence: 304.7] [Reference Citation Analysis]
100 Mesa A, Viñals C, Pueyo I 1st, Roca D, Vidal M, Giménez M, Conget I. The impact of strict COVID-19 lockdown in Spain on glycemic profiles in patients with type 1 Diabetes prone to hypoglycemia using standalone continuous glucose monitoring. Diabetes Res Clin Pract 2020;167:108354. [PMID: 32739380 DOI: 10.1016/j.diabres.2020.108354] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 14.0] [Reference Citation Analysis]
101 Pease A, Lo C, Earnest A, Kiriakova V, Liew D, Zoungas S. The Efficacy of Technology in Type 1 Diabetes: A Systematic Review, Network Meta-analysis, and Narrative Synthesis. Diabetes Technology & Therapeutics 2020;22:411-21. [DOI: 10.1089/dia.2019.0417] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
102 Préau Y, Armand M, Galie S, Schaepelynck P, Raccah D. Impact of Switching from Intermittently Scanned to Real-Time Continuous Glucose Monitoring Systems in a Type 1 Diabetes Patient French Cohort: An Observational Study of Clinical Practices. Diabetes Technol Ther 2021;23:259-67. [PMID: 33136439 DOI: 10.1089/dia.2020.0515] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
103 Argento NB. Flash forward, with caution. Diabet Med 2018;35:1131-2. [DOI: 10.1111/dme.13654] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]